QUARTUCCIO, NATALE
 Distribuzione geografica
Continente #
EU - Europa 2.003
NA - Nord America 486
AS - Asia 178
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.672
Nazione #
IT - Italia 1.508
US - Stati Uniti d'America 486
IE - Irlanda 220
SE - Svezia 183
CN - Cina 86
IN - India 42
VN - Vietnam 32
GB - Regno Unito 25
DE - Germania 22
FI - Finlandia 21
SG - Singapore 14
FR - Francia 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 3
UA - Ucraina 3
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
HK - Hong Kong 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
PT - Portogallo 1
Totale 2.672
Città #
Dublin 220
Milan 149
Nyköping 139
Chandler 120
Rome 108
Naples 64
Ashburn 37
Turin 36
Palermo 33
Dong Ket 32
Dearborn 30
Princeton 30
Medford 29
Beijing 26
Jacksonville 26
Genoa 25
Trieste 24
Bari 21
Hyderabad 21
Pune 20
Florence 19
Lancaster 19
Cambridge 18
Des Moines 18
Messina 16
Catania 15
Bergamo 14
Brescia 14
Bologna 13
Verona 12
Bremen 10
Cagliari 10
Jinan 10
Parma 10
San Mateo 9
Los Angeles 8
New York 8
Prato 8
Singapore 8
Nanchang 7
Pescara 7
Shenyang 7
Aversa 6
Ferrara 6
Modugno 6
Nanjing 6
Pisa 6
Syracuse 6
Taranto 6
Venice 6
Ancona 5
Cascina 5
Monza 5
Sarno 5
Trento 5
Treviso 5
Verdellino 5
Barletta 4
Boardman 4
Cassano delle Murge 4
Castel San Giorgio 4
Gragnano 4
Helsinki 4
Iesi 4
Lucca 4
Modena 4
Perugia 4
Ponte San Pietro 4
Porcia 4
Torrile 4
Wilmington 4
Ann Arbor 3
Augusta 3
Brno 3
Casavatore 3
Castel Rozzone 3
Castellammare di Stabia 3
Castelvetro di Modena 3
Civitanova Marche 3
Frosinone 3
Haikou 3
Hangzhou 3
Jiaxing 3
Melfi 3
Mogliano Veneto 3
Napoli 3
Nepi 3
Ningbo 3
Novellara 3
Oristano 3
Pederobba 3
Portici 3
Recanati 3
Reggio Calabria 3
San Giovanni in Persiceto 3
Sassari 3
Sorrento 3
Taizhou 3
Udine 3
Zhengzhou 3
Totale 1.676
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 1.555
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 95
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 65
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 65
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 52
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 52
Technetium-99m (99mTc)-labelled sulesomab in the management of malignant external otitis: is there any role? 51
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 49
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 48
Pediatric bone sarcoma: Diagnostic performance of 18 F-FDG PET/CT versus conventional imaging for initial staging and follow-up 47
Italian Multicenter Study on Accuracy of18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 46
A microdosimetric model of solid tumour microvasculature for radiopharmaceuticals labeled with 223 Ra, 111 In, 131 I and 177 Lu 44
The Role of 2deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography and Maximum Standardized Uptake Value in Predicting Prognosis of patients Wihth Non-Small Cell Lug Cancer in Different Stages (I-IV) 40
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing F-18-FDG PET/CT SUV quantification 40
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 40
Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma (Clinical and Translational Imaging, (2020), 8, 1, (3-10), 10.1007/s40336-019-00353-0) 40
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 40
Paediatric bone sarcoma: FDG-PET/CT vs. conventional imaging. A collaborative study 37
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 33
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 33
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review 32
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 32
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 30
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 30
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 28
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 27
Emerging applications of imaging in glioma: focus on PET/MRI and radiomics 20
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 11
The role of PET radiomic features in prostate cancer: a systematic review 10
Totale 2.692
Categoria #
all - tutte 7.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 1 1 2 27 14 6 4 4 10 0
2020/2021120 2 0 30 2 17 3 0 0 11 6 14 35
2021/2022163 1 18 0 6 22 1 8 7 1 13 19 67
2022/2023620 43 90 32 33 25 53 26 18 254 15 21 10
2023/20241.316 20 40 70 66 69 107 101 121 96 204 178 244
2024/2025288 212 76 0 0 0 0 0 0 0 0 0 0
Totale 2.692